ODDB.org: Open Drug Database

UCB-Pharma SA - Neupro 2 mg/24h, dispositif transdermique

Swissmedic Registration	57417	Sequence	08
Product name	Neupro 2 mg/24h	Description	dispositif transdermique
ATC-Classification	N04BC09	ATC-Description	Rotigotine
Introduction of Sequence	05.03.2014

Composition

rotigotinum 4.50 mg, silicone adhesive, povidonum K 90, E 223, E 304, E 307, poly(ethylenis terephthalas), ad praeparationem pro 10 cm², cum liberatione 2 mg/24h.

Packungsbestandteile

Galenic Form

dispositif transdermique

Active Agent	Dose
Rotigotine	4.5 mg

BAG: Active Agent	Dose
Rotigotine	4.5 mg

Inactive agents	Dose	additional_information
Ad Praeparationem	10 cm
Cum Liberatione	2mg / 24h
E 223		conserv.
E 304		conserv.
E 307		conserv.
Poly(Ethylenis Terephthalas)
Povidonum K	90
Silicone Adhesive

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
030	7	16.60	34.45	B	SL	No
031	28	54.44	75.60	B	SL	No

2025	©ywesee GmbH